The aim of this study was to evaluate the effect of age on the hemodynamic responses to intravenous (IV) ephedrine in pediatric patients anesthetized with halothane, nitrous oxide, and oxygen. One hundred ten pediatric patients, ranging in age from 0.1 to 15 yr, were assigned to receive 0.1 mg/kg (n = 55) or 0.2 mg/kg (n = 55) IV ephedrine. General anesthesia was maintained with 1.0 minimum alveolar anesthetic concentration (MAC) of halothane and 67% nitrous oxide in oxygen after tracheal intubation. Measurements of arterial blood pressure and heart rate were made at 1-min intervals for
10 min after ephedrine 0.1 or 0.2 mg/kg was injected IV as a bolus. Significant correlations were noted between age and changes in mean blood pressure (Y = 0.37, P < 0.01 for the subjects receiving ephedrine 0.1 mg/kg; Y = 0.63, P < 0.001 for the subjects receiving ephedrine 0.2 mg/kg), but not between age and changes in heart rate. The present results indicate that age correlates with the pressor but not the chronotropic effects of ephedrine in pediatric patients anesthetized with 1 MAC halothane and nitrous oxide. (Anesth Analg 1996; 82:568-73) H emodynamic effects of sympathomimetic or vagolytic substances change with developmental processes. There are several clinical reports showing that infants require more catecholamines such as dopamine (1) or dobutamine
(2) to achieve inotropic effects comparable to those seen in older children or adults. According to Palmisano et al.'s study in children (3) during halothane and nitrous oxide anesthesia, despite the occurrence of a positive chronotropic response, no pressor effect was noted from any doses of 5-40 pg/kg atropine in infants aged less than 6 mo, in contrast with children aged more than 2 yr. In addition, age-related functional changes in the autonomic nervous system are likely to modulate these altered vascular and myocardial responses to sympathomimetic or vagolytic agents in clinical settings (4).
The influence of age on vasoactive agent-induced hemodynamic changes in pediatric patients during anesthesia is not clear. Based on these considerations, we undertook this clinical study to test the hypothesis that developmental processes would alter the pressor effects of ephedrine, which possesses equal potency of CY-and P-receptor stimulation in adults (5), in pediatric patients anesthetized with 1.0 minimum alveolar anesthetic concentration (MAC) of halothane and nitrous oxide.
Methods
One hundred ten pediatric patients, ASA physical status I, ranging in age from 0.1 to 15 yr, scheduled to have general anesthesia for their surgical procedures, were selected for this study. The study protocol was approved by our institution's Human Studies Committee. Written, informed consent was obtained from the parent of each patient. No patient had any cardiovascular, pulmonary, or neurologic disorders. None of the patients received preanesthetic medication, such as sedatives or anticholinergic drugs. Standard monitoring was used. General anesthesia was induced with halothane 2% inspired and 67% nitrous oxide in oxygen by a mask using a T-piece circuit for infants and children weighing less than 15 kg and by a small circle system for those weighing more than 15 kg with a total fresh gas flow rate of 6 L/min. Two percent dextrose in lactated Ringer's solution was infused at an approximate rate of 568 Anesth Analg 1996;82:568-73 Patients were assigned to receive either 0.1 mg/kg (n = 55) or 0.2 mg/kg (n = 55) IV ephedrine. When a steady state of end-tidal halothane concentration and hemodynamic period of at least 5 min was established, ephedrine 0.1 or 0.2 mg/kg was injected IV as a bolus. Ephedrine hydrochloride solution was diluted in a concentration of 1 and 2 mg/mL for patients receiving ephedrine 0.1 and 0.2 mg/kg, respectively. Hemodynamic measurements were made at 1-min intervals for 10 min after the injection of ephedrine. Arterial blood pressure (BP) was measured oscillometrically with an appropriate cuff (Dynamap; Critikon, Tampa, FL). Heart rate (HR) was determined as the average of every 4 s from the electrocardiogram monitor. Immediately after to ephedrine were performed using the least-square method. A P value less than 0.05 was considered statistically significant.
Results
The patient's body height and weight ranged from 50 to 170 cm and from 3.8 to 68 kg, respectively. The differences in arterial blood gas tensions among groups were not significant ( Table 1 ). The end-tidal concentration of halothane was less in Group E than in Group A (P < 0.05) (Table 1) . Rectal temperature was maintained at 37.2 + 0.4"C during the study.
Baseline MBP values prior to ephedrine injection during general anesthesia were significantly greater in Groups C, D, and E compared with Group A in patients receiving ephedrine 0.1 mg/kg (P < 0.05, Table  2 ). Baseline MBP values were also higher in Groups D and E than in Groups A and B in patients receiving ephedrine 0.2 mg/kg (P < 0.05, Table 3 ). In contrast, baseline HR values were lower in older patients, and there were significant differences in basal HR among groups (P < 0.05, Tables 2 and 3) . Thus, age correlated with baseline MBP (Y = 0.56, P < 0.001) and baseline HR (r = -0.81, P < 0.001) (Fig. 1) .
There were no differences in baseline MBP and HR values in each group between patients receiving ephedrine 0.1 and 0.2 mg/kg (Tables 2 and 3) . MBP increased after ephedrine injection in 53 of 55 patients receiving ephedrine 0.1 mg/kg IV, but one patient each in Groups A and B showed no change and a decrease in MBP, respectively. After ephedrine 0.2 mg/kg IV, MBP increased in all 55 patients. The magnitudes of the MBP increase in Groups B, C, and D of patients receiving ephedrine 0.2 mg/kg were greater than those of patients receiving ephedrine 0.1 mg/kg (P < 0.05). Although HR increased in 43 of 55 patients after ephedrine 0.1 mg/kg injection, HR decreased or remained unchanged in the remainder of the patients (four, three, two, and three subjects in Groups A, C, D, and E, respectively).
In contrast, HR increased in all patients receiving ephedrine 0.2 mg/kg, but no statistical difference was found in HR changes between patients given ephedrine 0.1 and 0.2 mg/kg in any groups.
When compared in terms of absolute maximum changes from baseline MBP and HR values after ephedrine injection, there were no significant differences among groups of patients receiving ephedrine 0.1 mg/kg (Table 2 ). In contrast, in patients receiving ephedrine 0.2 mg/kg, the maximum changes in MBP from baselines were greater in Groups D and E compared with Group A and with Groups A, B, and C, respectively (Table 3 ). However, there was no difference among groups in HR changes after injection of ephedrine 0.2 mg/kg. Regression analysis revealed a stronger correlation between age and absolute maximum changes in MBP from baseline values in patients given ephedrine 0.2 mg/kg than in patients given ephedrine 0.1 mg/kg ( Figure 2 ). However, there was no significant correlation between age and absolute changes in HR after ephedrine (Y = 0.16 and 0.11 for patients receiving ephedrine 0.1 and 0.2 mg/kg, respectively).
In addition, when maximum percent change in HR was analyzed, there were no significant differences between the groups.
Discussion
The major finding in the current study is that age correlated with the pressor but not chronotropic effects of IV ephedrine 0.1 or 0.2 mg/kg in pediatric patients anesthetized with 1.0 MAC halothane and nitrous oxide. The correlation between age and maximum changes in MBP was more evident with the higher dose of ephedrine. In other words, older subjects had greater increases in MBP with the higher dose of ephedrine during 1 .O MAC halothane anesthesia. The underlying mechanism for this clinical finding remains unclear, and its elucidation is beyond the aim of this study.
The presence of age-related differences in baseline MBP and HR values during general anesthesia in the present results (Tables 2 and 3, and Figure 1) is consistent with a previous report (3). Similarly, evidence for age modulation of ephedrine's pressor effect in our study (Figure 1 ) agrees with previous reports demonstrating greater requirement of dopamine or dobutamine for circulatory improvement in infants with postcardiac surgery or shock compared with older children or adults (1,2). Despite several differences in patients' physical status and the pharmacological properties of pressor drugs between these studies and our own studies, the results obtained are similar with respect to age modulation of response to sympathomimetic drugs. However, one should consider factors that may account for only a poor correlation obtained between age and MBP changes ( Figure 2) . difference in maximum MBP changes among groups (Table 2) after ephedrine 0.1 mg/kg in our data. One possible explanation is that an inadequate dose of ephedrine may account for the present finding of an inapparent age effect due to a trivial pressor response elicited by ephedrine 0.1 mg/kg in most patients.
Since ephedrine exerts its pressor effect through facilitating norepinephrine release from sympathetic nerve terminals, in addition to its direct action, the potency of its pressor action can be modulated by circumstances such as the degree of development of the sympathetic nervous system with aging (7,8), the storage of norepinephrine (7) that is ready to be released after various stimuli, and the presence of anesthetics (9,lO) that may facilitate the release of norepinephrine. According to animal experiments demonstrating progressive increments of norepinephrine contents in the myocardium (7,ll) and augmentation of pressor 6 8 10 12 14
Age War) responses to norepinephrine (8) with advancing age, infants would show less pressor response to norepinephrine released after ephedrine compared with older children. Based on these considerations, our finding of agerelated alterations in the pressor responsiveness to ephedrine must be interpreted as the combined effects of several confounding variables. In other words, the magnitude of pressor effects of ephedrine in clinical settings is likely to be affected by different cardiovascular effects of general anesthetics with developmental processes and the hemodynamic and endocrine effects associated with the use of general anesthetics, as well as the developmental degree of the sympathetic nervous system per se.
It remains to be explained why we did not observe any differences in the chronotropic response to either dose of ephedrine with the developmental processes of aging. One can assume that greater suppression of baroreceptor reflex caused by general anesthetics in 
